aldesleukin,ict01
imcheck therapeutics,prometheus bio,iovance,novartis
['ict-01', 'eviction-2', 'imcheck']
imcheck's ict-01 drug achieves primary objectives in eviction-2 trial! low dose il-2 combo shows promise. more info: #pharmanews #aacr2023 $xbi $ibb $xph $pph
Latest BioPharma/Biotech News. Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  https://t.co/lvTtwarrGT